Submitted by Anonymous (not verified) on 30 November 2023 - 9:30
Human medicines European public assessment report (EPAR): Evusheld, tixagevimab,cilgavimab, COVID-19 virus infection, Date of authorisation: 25/03/2022, Revision: 6, Status: Authorised
Source: